Pharmacometrics: so much mathematics and why planes achieve their destinations with almost perfect results …

作者: Geoffrey K. Isbister , Robert Bies

DOI: 10.1111/BCP.12514

关键词:

摘要: The mention of population analysis or pharmacokinetic and pharmacodynamic (PKPD) modelling often sends clinicians clinical pharmacologists running, not wanting to know about mathematics understanding complexity. Individualized dosing, optimal design studies mechanistic models physiological processes are all ‘too hard’ leading another refrain – ‘and how do we apply this our practice?’ However, prepared use complex technology equipment in the practice medicine that requires high level mathematical complexity, but fear similar methods investigate, explore understand drug therapy, effects disease progression. Should be using most modern quantify pharmacology? Mathematics underlies much function, specifically expect pilots airlines advanced computers, simulations analytic techniques make flying safe. We rely on global position system (GPS) devices assist us arriving at destinations; require computer smartphone operating systems provide fundamental conveniences coordinate schedules, phone calls information utilize Google™ search for any number topics. So why struggle with them effects?

参考文章(19)
Jeffrey S. Barrett, Paediatric models in motion: requirements for model-based decision support at the bedside. British Journal of Clinical Pharmacology. ,vol. 79, pp. 85- 96 ,(2015) , 10.1111/BCP.12287
Mark Sale, Eric A. Sherer, A genetic algorithm based global search strategy for population pharmacokinetic/pharmacodynamic model selection. British Journal of Clinical Pharmacology. ,vol. 79, pp. 28- 39 ,(2015) , 10.1111/BCP.12179
Matthew M. Hutmacher, Kenneth G. Kowalski, Covariate selection in pharmacometric analyses: a review of methods. British Journal of Clinical Pharmacology. ,vol. 79, pp. 132- 147 ,(2015) , 10.1111/BCP.12451
Stephen B. Duffull, Daniel F. B. Wright, What do we learn from repeated population analyses British Journal of Clinical Pharmacology. ,vol. 79, pp. 40- 47 ,(2015) , 10.1111/BCP.12233
Joakim Nyberg, Caroline Bazzoli, Kay Ogungbenro, Alexander Aliev, Sergei Leonov, Stephen Duffull, Andrew C. Hooker, France Mentré, Methods and software tools for design evaluation in population pharmacokinetics-pharmacodynamics studies. British Journal of Clinical Pharmacology. ,vol. 79, pp. 6- 17 ,(2015) , 10.1111/BCP.12352
Holly Kimko, José Pinheiro, Model-based clinical drug development in the past, present and future: a commentary British Journal of Clinical Pharmacology. ,vol. 79, pp. 108- 116 ,(2015) , 10.1111/BCP.12341
Nick Holford, Clinical pharmacology = disease progression + drug action British Journal of Clinical Pharmacology. ,vol. 79, pp. 18- 27 ,(2015) , 10.1111/BCP.12170
Pedro L. Gambús, Iñaki F. Trocóniz, Pharmacokinetic-pharmacodynamic modelling in anaesthesia. British Journal of Clinical Pharmacology. ,vol. 79, pp. 72- 84 ,(2015) , 10.1111/BCP.12286
Nikolaos Tsamandouras, Amin Rostami-Hodjegan, Leon Aarons, Combining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data. British Journal of Clinical Pharmacology. ,vol. 79, pp. 48- 55 ,(2015) , 10.1111/BCP.12234
Stefan S. De Buck, Annamaria Jakab, Markus Boehm, Douglas Bootle, Dejan Juric, Cornelia Quadt, Timothy K. Goggin, Population pharmacokinetics and pharmacodynamics of BYL719, a phosphoinositide 3‐kinase antagonist, in adult patients with advanced solid malignancies British Journal of Clinical Pharmacology. ,vol. 78, pp. 543- 555 ,(2014) , 10.1111/BCP.12378